RyboDyn partners with U.S. Department of War to advance AI-discovered ADC therapies for Lung cancer

Lonza and InduPro announce licensing agreement to advance next-generation ADC therapeutics

Lonza grants Antharis exclusive license to develop dual-payload ADCs for GI cancers

AmMax Bio licenses antibody-drug conjugate technology for Hematological cancers from Lonza

Johnson & Johnson to acquire Firefly Bio to expand oncology pipeline with degrader ADC platform

Stipple Bio enters multi-target license agreement with Lonza to advance precision oncology ADC therapies

Mabion and KriSan Biotech sign letter of intent to explore ADC collaboration supporting strategic ambitions

Ratio Therapeutics and PharmaLogic expand manufacturing collaboration to support clinical development of [Ac-225]RTX-2358

Adcendo and MSD partner to evaluate ADCE-T02 plus KEYTRUDA in phase 1b advanced Solid tumor...